Objective: To discover the effects of the lowest hematocrit during cardiopulmonary bypass on end-organ function and mortality in patients who did not receive red blood cell transfusion and to identify predictors of nadir hematocrit.
However, the ability to discern whether adverse effects are attributable to nadir Hct is confounded by concomitant RBC transfusion, which itself introduces adverse effects. Thus, our objectives were to clarify the relationship between nadir Hct and end-or_gan function and mortality in cardiac surgical patients who were not transfused and to identify factors associated with nadir Hct.
METHODS Patients
From November 1, 2004, to October 1, 2009, 15,279 consecutive patients underwent cardiac surgery requiring CPB at the Cleveland Clinic. Of these, 7957 did not receive an RBC transfusion during or after surgery. The baseline demographics and perioperative variables were retrieved from the Cardiovascular Information Registry, a .prospective database updated concurrently with patient care (Table 1 ). The institutional review board approved the use of data from this registry for research, with patient consent waived.
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Abbreviations and Acronyms
CPB = cardiopulmonary bypass eGFR = estimated glomerular filtration rate Hct = hematocrit RBC = red blood cell
Endpoints
The endpoints were hospital morbidity and mortality, markers of endorgan function, resource usage, and long-term survival. Hospital morbidities (perioperative myocardial infarction, respiratory failure, sepsis, renal failure, and neurologic complications) were recorded prospectively according to definitions from the Society of Thoracic Surgeons National Adult Cardiac Database (available from: http://www.ctsnet.org/filelrptData Specifications252_l_ForVendorsPGS.pdf). Intensive care unit and postoperative lengths of stay were used as surrogates for resource use, as was the number of ventilator hours required postoperatively. Serial values of specific markers of end-organ function included troponin, estimated glomerular filtration rate (eGFR), and lactic acid.
Cardiovascubir Information Registry follow-up data supplemented with Social Security Death Master File information were used to determine the vital status. The median follow-up was 2.6 years (interquartile range, 1.3-3.9 years). A total of20,677 patient-years of follow-up were available for analysis; 25% of patients were followed more than 4 years and 10% for more than 4. 7 years.
Statistical Analysis
Patient demographics, perioperative risk factors, and postoperative outcomes were summarized using the median and interquartile range (continuous variables) or frequency counts and percentages ( categ~rical variables). Missing values were sporadic, without strong mechanism for informative missingness. They were imputed with the mean of available data (except for the cat~orical variable, New York Heart Association functional class, for which we created a separate category for its missing value). Of 7957 patients, 6928 (87.1 %) had 1 to 5 CPB Hct values. In general, an arterial blood sample was obtained every 30 minutes during CPB for measurement of Hc.t and lactate. Hct was not measured during CPB in 56 patients (0.7%); we used their lowest intraoperative Hct as a surrogate for nadir Hct during CPB.
The univariate relationship between nadir Hct and outcomes was explored using penalized spline models. The adjusted effect of nadir Hct on outcomes, given confounders, was analyzed using a generalized propensity score analysis. 15 Similar to the traditional 2-group propensity score analysis, 16 generalized propensity score analysis offers a method of stratifying patients such that within each stratum, nadir Hct and confounders appear to be ~lated. Thus, the association between nadir Hct and outcomes is unconfounded,within each stratum, and aggregated result across all strata forms an estimator of the independent effect of nadir Hct on outcomes (see Appendix El). Intraoperative Hct and lactic acid were measured simultaneously during surgery. We calculated their within-subject correlation and formed an average correlation coefficient. Its confidence interval was calculated using the bootstrap method.
We used a linear regression model with stepwise variable selection to identify preoperative risk factors associated with nadir Hct. Spline terms of continuous predictors were used to check the linearity assumption. The sandwich variance estimator was us~d to guard against possible heterogeneity or non-normality in the residual distribution.
All P values are 2-sided. Statistical analyses were performed with SAS, version 9.1 (SAS Institute, Cary, NC) and R 2.12.2 (R Foundation for Statistical Computing, Vienna, Austria).
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Perioperative Management
RESULTS
Unadjusted Nadir Bet and End-Organ Dysfunction
Nadir Hct ranged from 15% to 46% (median, 30%). Most often, the Hct level decreased from baseline shortly after beginning CPB and gradually recovered as the operation proceeded ( Figure El) .
The unadjusted association betw.eennadir Hct and selected outcomes is shown in Figure 1 . Nadir Hct was associated with lower eGFR and higher troponin levels, suggesting renal and myocardial injury were more likely with a lower nadir Hct. Nadir Hct had no significant association with intensive care unit length of stay. An inverse relationship was seen between nadir Hct and the duration of mechanical ventilation and hospital length of stay. On average, patients with a nadir Hct of 20% were discharged 2. 7 days later than patients with a nadir Hct of 35%. Three-year survival decreased from 98% to 85% as nadir Hct decreased from 35% to 20%.
Risk-Adjusted Nadir Bet and End-Organ Dysfunction
The risk-adjusted association of nadir Hct with each outcome is listed in Table 2 , and Figure 2 illustrates those relationships. In Table 2 , the associations are quantified as the regression coefficients of nadir Hct in the regression of each outcome, stratifying on the generalized propensity score. Nadir Hct was associated with higher mortality, more troponin release, lower eGFR, longer duration of mechanical ventilation, and longer length of hospital stay. Three-year adjusted survival decreased from 97% to 93% as nadir Hct decreased from 35% to 20%.
. Pearson's correlation was -0.12 (95% confidence interval, -0.16 to -0.076)between the maxilnum intraoperative lactic acid level and nadir Hct, as determined from 2156 .· patients with available )actic acid data. A within-subject correlation analysis of 1893 patients, each with at least 5 pairs of intraoperative Hct and lactic acid measurements, showed that the average within-subject correlation coefficient l;>_etween intraoperative Hct and lactic acid level was -0.44 (95% confidence interval, -0.45 to -0.42). Both results suggest impaired tissue perfusion at lower Hct values. Sensitivity analyses using multivariate models were performed to confirm the results of the generalized propensity score analysis. We built regression models for the key outcomes using the variables listed in Table 1 . The sensitivity analysis produced consistent results with the generalized propensity score analysis. Nadir Hct was associated with lower eGFR, greater troponi.D. release, longer postoperative ventilation time, ·longer hospital length of stay, lower survival, and an increase in late mortality (see Appendix E2 and Tables El to E7).
Risk Factors for Nadir Hct
The factors associated with lower nadir Hct included lower preoperative Hct, older age, female gender, lower body mass fudex, peripheral arterial disease, renal disease, procedure complexity, and longer CPB duration ( Table 3 ). The strongest correlate was preoperative Hct, with a Pearson correlation coefficient of 0.74. With all other variables fixed, older age, lower body mass index, higher New York Heart Association functional classification, and longer duration of CPB were associated with a decrease in predicted nadir Hct (Figure 3 ).
DISCUSSION
A restrictive RBC transfusion strategy is integral to current blood management programs for cardiac surgery. Part of this strategy is a tolerance for perioperative anemia, but without the ability to predict whether a given level of anemia is safe. In our study, nadir Hct was associated with more end-organ dysfunction and mortality in a cohort of nontransfused cardiac surgical patients.
Other studies have explored the influence of anemia on surgical outcomes; however, many of these studies did not control for the concomitant influence of RBC transfusion. Moreover, the effects of preoperative· anemia are difficult to separate from the effects of anemia occurring during CPB. Approximately 25% to 30% of patients undergoing cardiac surgery are anemic before the procedure, and this support, logistic regression analysis was used, and the effect is the log odds ratio; for survival, the Cox model was used, and the effect is the log hazard ratio. tNaturallogarithrnic transformation.
is a recognized risk factor for increased morbidity and mortality. [18] [19] [20] Lower nadir Hct during CPB has been associated with increased in-hospital and long-term mortality. 6 • 7 A recent study investigated the influence of nadir Hct on mortality in a group of nontransfused patients undergoing isolated coronary artery bypass grafting. 3 The investigators found an increase in major morbidity related to nadir Hct, but no effect on survival. Two small randomized trials failed to demonstrate a difference in operative, in-hospital, or 1-year survival for patients with low Hct during CPB.
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To investigate the relationship between anemia and poor outcomes, we examined laboratory markers for end-organ function with varying Hct levels. Swaminathan and colleagues2 showed that nadir Hct during CPB was associated with a higher peak fractional change in creatinine and that RBC transfusion further exacerbated the effects of low nadir Hct on renal function. Others have reported the susceptibility of renal function to low nadir Hct, as reflected by increased creatinine values and renal failure. 5 We discovered a significant interaction between nadir Hct and eGFR. Patients progressed along a spectrum of mild renal dysfunction as nadir Hct decreased from 30% to 20%. This is a subtle, but important, finding. Previous studies have shown that even mild degrees of renal dysfunction can influence adverse outcomes among patients undergoing cardiac surgery.Z
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Patients with a low nadir Hct have a greater prevalence of postoperative myocardial infarction, cardiac arrest, 6 intraaortic balloon pump use, and return to CPB. 6 • 7 We did not find an association between nadir Hct and Society of Thoracic Surgeons-defined postoperative myocardial Loor et:
infarction. However, we did note a relationship betwef nadir Hct and the release of troponin. This subclinic myocardial injury can be explained by a low nadir Hct · the cardioplegia solution, which derives its Hct fro: systemic circulation. The nadir Hct is often reachf shortly after the initiation of CPB and before the period ' protected ischemic arrest, which might explain tb increase in troponin .. Although the implications of tb troponin release are unclear, it has been shown to 1 a sensitive marker for perioperative myocardial infarcti< and postoperative heart failure. 26 • 27
The increased hospital· length of stay associated wi lower nadir Hct might be related to fatigue-induced la' of mobility in the immediate postoperative period. A rece study reported that postoperative cardiac surgery patie1J admitted to rehabilitation with hemoglobin values le than 10 g/dL had significantly worse performance on tJ 6-minute walk test than patients with higher hemoglob values. 28 
Study Limitations
This was a prospective cohort investigation in which u measured variables could have biased the results from t generalized propensity score analysis and regressi' models. However, we improved on previous studies by i corporating a larger number of confounders into our mod including preoperative anemia. Patients in the present i vestigation were lower risk than patients who receiv blood transfusions, as previously demonstrated by a group. 10 • 11 Nadir Hct was analyzed as a continuo variable, and we found no threshold below which t morbidity sharply increased to suggest a sharp cuto Furthermore, our analysis showed that the effect of na' Hct was different for individual organ systems and v. affected by the patients' unique comorbidities. Thus, ' cannot recommend a subject-or morbidity-specific transJ sian trigger.
Clinical Implications
We identified several risk factors for low nadir Hct CPB that could guide patient selection and preoperati management. Preoperative anemia should be investigat for potentially reversible causes, and, if possible, surg( should be delayed until Hct improves. The observati that women had a lower preoperative Hct was consistc with previous work from our group. 29 Iron suppleme: and short-term therapy with erythropoietin are possible terventions. A number of intraoperative strategies can an liorate reductions in Hct associated with surgery requiri CPB. Retrograde autologous priming and smaller byp: circuits are encouraged in patients with a low body mass dex and low preoperative Hct. Many of these blood cons vation strategies have been implemented at our instituti during the past decade. These strategies did not conf~u 15  20  25  30  35  40  45  15  20  25  30  35  40  45 Hematocrit(%) Hematocrit(%) FIGURE 2. Adjusted relationship between nadir hematocrit (Hct) and outcomes from generalized propensity score analysis. Gray lines indicate therelationship within each patient strata defined by the generalized propensity score. Fifty strata were used, representing a spectrum of risk levels (except for all-cause death, for which we combined 50 strata into 5 to estimate the baseline s~iva! probability accurately). Solid line indicates average across all strata. Fo~. comparison purposes, the dashed lines represent the same moHel between outcomes and nadir Hct without stratification. eGFR, Estimated glomerular filtration rate; ICU, intensive care unit. · our ability to examine the effect of nadir Hct on outcomes; rather, they reduced the overill level of anemia experienced by patient population. The relationship between New York Heart Association functional class and nadir Hct was most likely due to the patients' excess fr~e water coupled with the CPB priming solution. These patients should undergo diuresis before surgery to help avoid lower nadir Hct.
Future studies should address factors that can help define subgroups of ·patients with severe intraoperative anemia who would benefit from RBC transfusions. The risks of tolerating a lower Hct must be weighed against the risks of interventions used to increase it, such as RBC transfusion._ To date, evidence has suggested that patients do worse when given RBC products during cardiac surgery. Specifically, for reasons that are not entirely understood, patients who
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